GH Research Correlations
| GHRS Stock | USD 11.72 0.69 6.26% |
The correlation of GH Research is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as GH Research moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if GH Research PLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Significant diversification
The correlation between GH Research PLC and NYA is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding GH Research PLC and NYA in the same portfolio, assuming nothing else is changed.
GHRS |
The ability to find closely correlated positions to GH Research could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GH Research when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GH Research - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GH Research PLC to buy it.
Moving together with GHRS Stock
| 0.83 | OPT | Opthea | PairCorr |
| 0.67 | PBH | Prestige Brand Holdings Financial Report 2nd of May 2024 | PairCorr |
| 0.67 | PAHC | Phibro Animal Health Financial Report 1st of May 2024 | PairCorr |
Moving against GHRS Stock
| 0.76 | PCRX | Pacira Pharmaceuticals Financial Report 1st of May 2024 | PairCorr |
| 0.66 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
| 0.55 | ANAB | AnaptysBio Financial Report 9th of May 2024 | PairCorr |
| 0.54 | GNTA | Genenta Science SpA Report 24th of April 2024 | PairCorr |
| 0.53 | MGTX | MeiraGTx Holdings PLC Financial Report 9th of May 2024 | PairCorr |
| 0.52 | ALKS | Alkermes Plc Financial Report 24th of April 2024 | PairCorr |
| 0.46 | EVO | Evotec SE ADR Earnings Call Tomorrow | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between GHRS Stock performing well and GH Research Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze GH Research's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| MOLN | 2.58 | (0.40) | 0.00 | 0.83 | 0.00 | 4.90 | 23.10 | |||
| MNOV | 2.04 | (0.12) | 0.00 | (0.30) | 0.00 | 4.55 | 14.01 | |||
| ANEB | 2.62 | 0.25 | 0.03 | (0.40) | 3.49 | 6.20 | 20.75 | |||
| CSBR | 2.12 | (0.37) | 0.00 | 0.50 | 0.00 | 4.60 | 11.67 | |||
| CYT | 0.70 | (0.03) | 0.00 | (1.20) | 0.00 | 1.64 | 4.87 | |||
| MLYS | 3.03 | 0.28 | 0.12 | 0.18 | 3.22 | 6.29 | 26.82 | |||
| ELYM | 3.71 | 0.80 | 0.16 | (0.79) | 3.08 | 4.17 | 77.43 | |||
| JANX | 8.98 | 4.14 | 1.05 | 1.91 | 2.78 | 12.06 | 240.08 | |||
| RZLT | 4.71 | 1.97 | 0.41 | 1.14 | 3.70 | 12.17 | 21.05 | |||
| PMVP | 3.07 | (0.21) | 0.00 | (0.52) | 0.00 | 6.67 | 21.67 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in GH Research without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
| All Next | Launch Module |
GH Research Corporate Management
Elected by the shareholders, the GH Research's board of directors comprises two types of representatives: GH Research inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GHRS. The board's role is to monitor GH Research's management team and ensure that shareholders' interests are well served. GH Research's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GH Research's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Naoise Gaffney | VP Property | Profile | |
| Julie ACA | VP Fin | Profile | |
| Magnus Halle | CoFounder Ireland | Profile | |
| Velichka MD | Chief Officer | Profile | |
| Florian M | CoFounder Chairman | Profile | |
| Theis MD | CoFounder CEO | Profile | |
| Aaron MBA | Chief Officer | Profile |
Already Invested in GH Research PLC?
The danger of trading GH Research PLC is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of GH Research is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than GH Research. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile GH Research PLC is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether GH Research PLC is a strong investment it is important to analyze GH Research's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact GH Research's future performance. For an informed investment choice regarding GHRS Stock, refer to the following important reports: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GH Research PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for GHRS Stock analysis
When running GH Research's price analysis, check to measure GH Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GH Research is operating at the current time. Most of GH Research's value examination focuses on studying past and present price action to predict the probability of GH Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GH Research's price. Additionally, you may evaluate how the addition of GH Research to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
Is GH Research's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GH Research. If investors know GHRS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GH Research listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.68) | Return On Assets (0.11) | Return On Equity (0.15) |
The market value of GH Research PLC is measured differently than its book value, which is the value of GHRS that is recorded on the company's balance sheet. Investors also form their own opinion of GH Research's value that differs from its market value or its book value, called intrinsic value, which is GH Research's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GH Research's market value can be influenced by many factors that don't directly affect GH Research's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GH Research's value and its price as these two are different measures arrived at by different means. Investors typically determine if GH Research is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GH Research's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.